Provided by Tiger Trade Technology Pte. Ltd.

CDT Equity

1.36
-0.0900-6.21%
Post-market: 1.34-0.0200-1.47%19:59 EDT
Volume:334.39K
Turnover:476.85K
Market Cap:1.53M
PE:0.00
High:1.56
Open:1.45
Low:1.34
Close:1.45
52wk High:44,450.00
52wk Low:1.34
Shares:1.12M
Float Shares:801.60K
Volume Ratio:0.46
T/O Rate:41.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-135,009.1700
EPS(LYR):-294,474.4742
ROE:-69.68%
ROA:-23.44%
PB:0.01
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
CDT Equity
Exchange:
NASDAQ
Establishment Date:
2019
Employees:
- -
Office Location:
4581 Tamiami Trail North,Suite 200,Naples,Florida,United States
Zip Code:
34103
Fax:
- -
Introduction:
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Directors

Name
Position
James Bligh
Chief Executive Officer and Chief Financial Officer and Director
Chele Chiavacci Farley
Chairperson of the Board and Director
Simon Fry
Director
Ulrik Olsen
Director

Shareholders

Name
Position
James Bligh
Chief Executive Officer and Chief Financial Officer and Director